恶性输液和免疫性瘤衍生的外体
Fabrice Andre1, Noel E C Schartz, Mojgan Movassagh
1Departments of Clinical Biology, Immunology Unit, Institut Gustave Roussy, Villejuif, France.
Lancet (London, England)
|July 31, 2002
概括
在恶性排泄物中发现的瘤衍生外体可用于产生瘤特异性T细胞. 这些ascites外基因组作为瘤抗原的新型来源,用于癌症免疫疗法开发.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 瘤衍生的外体是癌细胞释放的囊泡.
- 研究了外基因组在体内发挥的作用及其在癌症免疫治疗中的潜力.
- 恶性排泄物被检查出瘤外体的存在.
研究的目的:
- 为了确定恶性溢出中的瘤外体能否诱导瘤特异性T细胞.
- 探索炎外体的潜力,作为癌症疫苗瘤抗原的来源.
主要方法:
- 从11个恶性排泄物中用超离心法分离出外体.
- 外基因组的表征涉及西斑,免疫电子显微镜和体外T细胞刺激.
- 自主树突细胞与阿西特斯外体脉冲,以扩大瘤特异性T细胞.
主要成果:
- 恶性排泄物含有大量的外体 (平均直径80纳米),表达MHC类I,CD81和瘤抗原 (Her2/Neu,Mart1,TRP,gp100).
- 黑色素瘤外体将Mart1瘤抗原传递给树突细胞,以进行T细胞交叉呈现.
- 在7/9名癌症患者中,瘤特异性T细胞通过脉动自主树突细胞与瘤外体进行扩大.
结论:
- 瘤外基因组积聚在癌症患者的瘤中.
- 阿西特外基因组代表了瘤排斥抗原的新型来源.
- 这些发现表明了开发癌症免疫疗法的新策略.
相关概念视频
Cell-mediated Immune Responses
Overview
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


